"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on N…
Suicide is the tenth leading cause of death in the United States, and each year 44,965 people die by suicide. Additionally, for every completed suicide, 25 individuals attempt suicide. Previous research has identified several risk factors associated with suicide, such as mental …
Background and purpose: Formerly incarcerated people die by suicide at a rate 6.75 times higher than the general population, but previous research has not identified factors that contribute to this heightened risk. The conditions of the COVID-19 pandemic may exacerbate both suic…
The Suicide and Homicide Risk Assessment & Prevention Treatment Planner provides all the elements necessary to quickly and easily develop formal treatment plans that satisfy the demands of HMOs, managed care companies, third-party payors, and state and federal review agencies. …
This timesaving resource features: -Treatment plan components for 27 behaviorally based presenting problems -Over 1,000 prewritten treatment goals, objectives, and interventions-plus space to record your own treatment plan options -A step-by-step guide to writing treatment plans…
It is estimated that 45 to 50 percent of all Americans will suffer a mental disorder at some time during their lives. Increasingly, the treatment for these disorders is management with one or more psychiatric drugs, often prescribed by general practitioners. In Pillaged, Ronald …
Increasingly, the treatment for mental disorders is management with one or more psychiatric drugs, often prescribed by general practitioners. Ronald William Maris evaluates the psychiatric medications commonly used to treat several major types of psychiatric disorders - includin…